{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:05:28Z","timestamp":1787317528178,"version":"build-2736575974"},"reference-count":50,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,12]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n                  <jats:p>\n                    The effects of azithromycin mass drug administration (MDA) on trachoma and yaws have been addressed. However, the secondary effects of azithromycin MDA remain unclear. This study aimed to explore the secondary effects of azithromycin MDA. PubMed, Embase, Cochrane Library, Web of Science, and ClinicalTrials.gov were searched from conception to January 5, 2022. Studies on secondary effects of azithromycin MDA were included. A total of 34 studies were included. Six of them reported on child mortality, 10 on malaria, and 20 on general morbidity and condition. Azithromycin MDA reduced child mortality, and quarterly MDA may be most beneficial for reducing child mortality. The effect of azithromycin MDA on malaria was weak. No association was observed between azithromycin MDA and malaria parasitemia (rate ratio: 0.71, 95% confidence interval: 0.43\u20131.15). Azithromycin MDA was associated with a lower risk of respiratory tract infections and diarrhea. Additionally, it was associated with a lower risk of fever, vomiting, and headache. The carriage of pathogenic organisms such as\n                    <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                    and gut\n                    <jats:italic>Campylobacter<\/jats:italic>\n                    species was reduced. However, these secondary effects of azithromycin MDA appeared to last only a few weeks. Moreover, no association was observed between azithromycin MDA and nutritional improvement in children. In conclusion, azithromycin MDA had favorable secondary effects on child mortality and morbidity. However, the effects were short term.\n                  <\/jats:p>","DOI":"10.4269\/ajtmh.22-0134","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T10:05:10Z","timestamp":1660557910000},"page":"904-911","source":"Crossref","is-referenced-by-count":9,"title":["Secondary Effects from Mass Azithromycin Administration: A Systematic Review and Meta-analysis"],"prefix":"10.4269","volume":"107","author":[{"given":"Jinhui","family":"Li","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imti","family":"Choonara","sequence":"additional","affiliation":[{"name":"Academic Division of Child Health, University of Nottingham, Derbyshire Children\u2019s Hospital, Derby, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamim","family":"Qazi","sequence":"additional","affiliation":[{"name":"World Health Organization, Department of Maternal Newborn Child and Adolescent Health, Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhi","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China;"},{"name":"Department of Pharmacy, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, Chengdu, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Trachoma Control: A Guide for Programme Managers","year":"2006"},{"key":"b2","series-title":"Bull World Health Organ","first-page":"844","article-title":"Global data on visual impairment in the year 2002","volume":"82","year":"2004"},{"key":"b3","series-title":"Achieving Community Support for Trachoma Control: A Guide for District Health Work","year":"1995"},{"key":"b4","year":"2022"},{"key":"b5","series-title":"Chin Med J (Engl)","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1097\/CM9.0000000000001717","article-title":"The effectiveness of azithromycin mass drug administration on trachoma: a systematic review","volume":"134","year":"2021"},{"key":"b6","series-title":"PLoS Med","doi-asserted-by":"publisher","first-page":"e1002835","DOI":"10.1371\/journal.pmed.1002835","article-title":"Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: a cluster-randomized, placebo-controlled trial","volume":"16","year":"2019"},{"key":"b7","series-title":"Pediatr Infect Dis J","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/INF.0b013e31824155c9","article-title":"Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children","volume":"31","year":"2012"},{"key":"b8","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4269\/ajtmh.2011.11-0046","article-title":"Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children","volume":"85","year":"2011"},{"key":"b9","series-title":"Engl J Med","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/NEJMoa1715474","article-title":"Azithromycin to reduce childhood mortality in Sub-Saharan Africa","volume":"378","year":"2018"},{"key":"b10","series-title":"Eur J Clin Pharmacol","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s00228-020-02956-3","article-title":"Safety of azithromycin in pediatrics: a systematic review and meta-analysis","volume":"76","year":"2020"},{"key":"b11","series-title":"Lancet Infect Dis","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S1473-3099(18)30444-4","article-title":"Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review","volume":"19","year":"2019"},{"key":"b12","series-title":"Lancet Infect Dis","first-page":"e14","article-title":"Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review","volume":"19","year":"2018"},{"key":"b13","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1056\/NEJMoa1811400","article-title":"Effect of adding azithromycin to seasonal malaria chemoprevention","volume":"380","year":"2019"},{"key":"b14","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa1817213","article-title":"Longer-term assessment of azithromycin for reducing childhood mortality in Africa","volume":"380","year":"2019"},{"key":"b15","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/cid\/cir069","article-title":"Childhood mortality in a cohort treated with mass azithromycin for trachoma","volume":"52","year":"2011"},{"key":"b16","series-title":"PLoS Negl Trop Dis","first-page":"1082","article-title":"Childhood mortality after mass distribution of azithromycin: a secondary analysis of the PRET cluster-randomized trial in Niger","volume":"37","year":"2018"},{"key":"b17","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2009.1266","article-title":"Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial","volume":"302","year":"2009"},{"key":"b18","series-title":"Malar J","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12936-019-2914-8","article-title":"The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study","volume":"18","year":"2019"},{"key":"b19","series-title":"Trop Med Int Health","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/tmi.12234","article-title":"Effect of azithromycin mass drug administration for trachoma on spleen rates in Gambian children","volume":"19","year":"2014"},{"key":"b20","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.4269\/ajtmh.19-0619","article-title":"Effects of biannual azithromycin mass drug administration on malaria in malawian children: a cluster-randomized trial","volume":"103","year":"2020"},{"key":"b21","series-title":"Emerg Infect Dis","first-page":"941","article-title":"Short-term malaria reduction by single-dose azithromycin during mass drug administration for trachoma, Tanzania","volume":"20","year":"2014"},{"key":"b22","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4269\/ajtmh.13-0379","article-title":"Impact of mass azithromycin distribution on malaria parasitemia during the low-transmission season in Niger: a cluster-randomized trial","volume":"90","year":"2014"},{"key":"b23","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4269\/ajtmh.16-0487","article-title":"Mass azithromycin and malaria parasitemia in Niger: results from a community-randomized trial","volume":"97","year":"2017"},{"key":"b24","series-title":"Pediatr Infect Dis J","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/INF.0000000000001813","article-title":"Annual versus biannual mass azithromycin distribution and malaria parasitemia during the peak transmission season among children in Niger","volume":"37","year":"2018"},{"key":"b25","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(95)92712-3","article-title":"Effects of azithromycin on malariometric indices in The Gambia","volume":"346","year":"1995"},{"key":"b26","series-title":"Pediatr Infect Dis J","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1097\/00006454-199911000-00003","article-title":"Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children","volume":"18","year":"1999"},{"key":"b27","series-title":"Open Forum Infect Dis","doi-asserted-by":"publisher","first-page":"ofy182","DOI":"10.1093\/ofid\/ofy182","article-title":"Mass azithromycin distribution and community microbiome: a cluster-randomized trial","volume":"5","year":"2018"},{"key":"b28","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41591-019-0533-0","article-title":"Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution","volume":"25","year":"2019"},{"key":"b29","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/clinids\/24.3.356","article-title":"A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.","volume":"24","year":"1997"},{"key":"b30","series-title":"Antimicrob Agents Chemother","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1128\/AAC.47.9.2765-2769.2003","article-title":"Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae.","volume":"47","year":"2003"},{"key":"b31","series-title":"Bull World Health Organ","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2471\/BLT.13.133462","article-title":"Mass administration of azithromycin and Streptococcus pneumoniae carriage: cross-sectional surveys in The Gambia","volume":"92","year":"2014"},{"key":"b32","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1093\/cid\/cit137","article-title":"Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment","volume":"56","year":"2013"},{"key":"b33","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1086\/341414","article-title":"Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal","volume":"35","year":"2002"},{"key":"b34","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1086\/655697","article-title":"The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma","volume":"51","year":"2010"},{"key":"b35","series-title":"PLoS Med","doi-asserted-by":"publisher","first-page":"e1000377","DOI":"10.1371\/journal.pmed.1000377","article-title":"Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial","volume":"7","year":"2010"},{"key":"b36","series-title":"Clin Infect Dis","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1093\/cid\/ciaa606","article-title":"Reduction of coronavirus burden with mass azithromycin distribution","volume":"71","year":"2020"},{"key":"b37","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4269\/ajtmh.2012.12-0284","article-title":"A cluster-randomized controlled trial evaluating the effects of mass azithromycin treatment on growth and nutrition in Niger","volume":"88","year":"2013"},{"key":"b38","series-title":"PLoS Negl Trop Dis","doi-asserted-by":"publisher","first-page":"e0007442","DOI":"10.1371\/journal.pntd.0007442","article-title":"Linear growth in preschool children treated with mass azithromycin distributions for trachoma: a cluster-randomized trial","volume":"13","year":"2019"},{"key":"b39","series-title":"PLoS Negl Trop Dis","doi-asserted-by":"publisher","first-page":"e3128","DOI":"10.1371\/journal.pntd.0003128","article-title":"Does mass azithromycin distribution impact child growth and nutrition in Niger? A cluster-randomized trial","volume":"8","year":"2014"},{"key":"b40","series-title":"BMC Public Health","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1186\/1471-2458-14-1176","article-title":"Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control","volume":"14","year":"2014"},{"key":"b41","series-title":"Trop Med Int Health","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/tmi.13390","article-title":"Effect of adding azithromycin to the antimalarials used for seasonal malaria chemoprevention on the nutritional status of African children","volume":"25","year":"2020"},{"key":"b42","series-title":"PLoS Negl Trop Dis","doi-asserted-by":"publisher","first-page":"e0006950","DOI":"10.1371\/journal.pntd.0006950","article-title":"Safety of azithromycin in infants under six months of age in Niger: a community randomized trial","volume":"12","year":"2018"},{"key":"b43","series-title":"J Glob Health","first-page":"010415","article-title":"Direct estimates of national neonatal and child cause-specific mortality proportions in Niger by expert algorithm and physician-coded analysis of verbal autopsy interviews","volume":"5","year":"2015"},{"key":"b44","series-title":"Lancet Glob Health","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1016\/S2214-109X(19)30540-6","article-title":"Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial","volume":"8","year":"2020"},{"key":"b45","series-title":"Am J Trop Med Hyg","first-page":"1291","article-title":"Efficacy of mass azithromycin distribution for reducing childhood mortality across geographic regions","volume":"103","year":"2019"},{"key":"b46","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.4269\/ajtmh.18-1004","article-title":"Effect modification by baseline mortality in the MORDOR azithromycin trial","volume":"103","year":"2020"},{"key":"b47","series-title":"Am J Trop Med Hyg","doi-asserted-by":"publisher","first-page":"691","DOI":"10.4269\/ajtmh.18-0846","article-title":"Mass azithromycin distribution to prevent childhood mortality: a pooled analysis of cluster-randomized trials","volume":"100","year":"2019"},{"key":"b48","series-title":"Clin Infect Dis","first-page":"2114","article-title":"Mass oral azithromycin for childhood mortality: timing of death after distribution in the MORDOR trial","volume":"68","year":"2018"},{"key":"b49","series-title":"Med Clin (Barc)","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.medcli.2020.05.010","article-title":"Update on malaria","volume":"155","year":"2020"},{"key":"b50","series-title":"BMC Microbiol","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12866-017-0982-x","article-title":"Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control","volume":"17","year":"2017"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/107\/4\/article-p904.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/107\/4\/article-p904.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/107\/4\/article-p904.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T12:11:12Z","timestamp":1665576672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/107\/4\/article-p904.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":50,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.22-0134","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]}}}